Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • crh
    Member
    • Dec 2009
    • 46

    #1

    DESeq2 experimental design/analysis

    Nieve statistical question

    We have the following data:
    control: 3 biological replicates
    treatment 1: 2 biological replicates
    treatment 2: 2 biological replicates

    Using DESeq2 and running 3 separate comparisons we get:
    1. ctl vs treatment 1 ~ 160 genes up-regulated
    2. ctl vs treatment 2 ~ 660 genes up-regulated
    3. treatment1 vs treatment 3 ~ NO genes up-regulated

    So, if we compare data from 1 & 2 we get ~ 500 genes differentiially up-regulated between treatment 1 : treatment2, but none if we compare them directly (#3).

    I assume this means T1 & T2 distributions are nearly identical, and differ from the control.

    Correct?

    Charles
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    I don't know about "nearly identical", but they're less likely to be different than the control condition (note my weird wording, which allows for cases where the variance in the treatment groups is high whereas that in the control group is low...which can also lead to findings like this). BTW, you probably want to check down-regulated genes as

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    18 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    26 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-13-2026, 09:56 AM
    0 responses
    22 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-09-2026, 11:14 AM
    0 responses
    28 views
    0 reactions
    Last Post SEQadmin2  
    Working...